Flexible EBR in the regulated pharmaceutical environment – GxP-compliant and future-proof
Categories
The pharmaceutical industry is facing major challenges: Strict regulations (validation, ER/ES, audit trail, data integrity, data consistency, etc.) must be met, while at the same time customers expect innovation, fast delivery times and a broad product range – all while maintaining consistently high, defined quality.
What if the first step to solving your challenges could be found in this article?
A Highly Flexible, Validated EBR – The Key to Success
A modern EBR system that allows the user to create recipes from predefined building blocks within minutes and then publish them digitally is the answer to current requirements.
The advantages are clear:
-
Dynamic Recipe Processing: Recipes can be created directly by the user, read into the system, then efficiently validated and integrated into the production process.
-
Digital Publication and Real-Time Monitoring: Once production data is captured, the system can automatically publish reports and batch records digitally. Production data can be transferred live to data historians or data lakes, enabling real-time production control and quality improvement.
This gives operators, managers and external stakeholders, such as quality control teams, timely actual data for control, monitoring and release. During audits, the time-consuming process of data preparation is eliminated, as all required data is stored in a structured manner and can be accessed at any time.
GxP Compliance and Validatability – No Room for Compromise
In the regulated environment of the pharmaceutical industry, it is essential that every IT system complies with GxP (Good Practice) requirements. A flexible EBR system must therefore meet certain requirements:
- Data Security and Integrity: Protection against unauthorized access and traceability of all changes.
- Audit Trail: Traceability of every step and every change in the system. This means: All entries, changes and corrections are documented and verifiable in the system.
- Electronic Records/Electronic Signatures (ER/ES): Documentation and verifiability of all entries, changes and corrections. Every step in the production process and every change in the system must be traceable.
- Validatability: Verification under real conditions. This is a critical requirement of the FDA and other regulatory authorities worldwide.
Benefits for the Pharmaceutical Industry
The introduction of a highly flexible, GxP-compliant and validatable EBR system brings numerous benefits:
-
Improved Compliance: Fulfillment of all regulatory requirements and reduction of non-compliance risk.
-
Higher Production Efficiency: Shortened production times and more efficient use of resources through digitalization of batch documentation and dynamic recipe adjustment.
-
Error Reduction: Minimization of manual error sources through automatic reading and processing of recipes. This increases product quality and reduces the risk of production failures or recalls.
-
Cost Savings: Long-term cost savings through improved efficiency and error reduction, both in production and in compliance with regulatory requirements.
Conclusion: A Future-Proof System for the Pharmaceutical Industry
A highly flexible, GxP-compliant, and validatable EBR system like anicomply represents a significant advancement for the pharmaceutical industry. The digitalization of batch recording not only offers a more efficient production method but also increased compliance security. Given the increasing regulatory requirements and the pressure to optimize processes, investing in a modern EBR system is a clear step towards the future.
Implementing such a system enables pharmaceutical companies to respond agilely and efficiently to market changes while meeting the highest quality and safety standards.
For further information or a product demonstration please contact us.